Healthcare and Pharmaceuticals industry

Precision Medicine market 2020 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Precision medicine initiative aims to use advances in clinical and basic research to develop therapeutics that selectively target and kill cancer cells. This allows researchers to develop chemically tractable probes that can image cancer in Vivo. Precision medicine is used to treat children or adolescent patients suffering from brain tumor that have no other effective therapies. Various companies are continuously investing in research and development to further refine precision medicines for interventional surgical imaging, as well as for diagnostic and therapeutic applications. In 2015, Pfizer, Inc. established Center of Excellence in Precision Medicine (CEPM) in Chile, in partnership with Thermo Fisher Scientific, to validate new, more precise, and less invasive technologies for diagnosing cancer.

Furthermore, precision medicine is proving to be effective in treating oncology-related diseases, cardiovascular diseases, psychiatric disorders, neurodegenerative diseases, arthritis, obesity, diabetes, pain, and Alzheimer's disease. Reduced cost of treatment attracts patient toward the precision medicine, as precision medicine cuts down most of the expensive treatments, which are not required since genetic testing helps the oncologists offer precision medicine.
Market Dynamics
The two recent FDA drug approvals, Kalydeco (ivacaftor) and Keytruda (pembrolizumab), pertaining to 33 cystic fibrosis mutations and cancer treatment based on a genetic feature respectively, point to an encouraging future for precision medicine. National Cancer Institute (NCI) conducts NCI-COG Pediatric MATCH trial that enrolls children and adolescents by advanced cancer therapy based on their genetic abnormality, where NCI also plans to support new immunotherapy clinical trials, antibody, testing of new combinations of the cell, small molecule, and radiation therapy studies, which include sequencing of tumor specimens. In July 2017, NCI has also launched various precision medicine trials, which include Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials (ALCHEMIST), Lung Cancer Master Protocol (Lung-MAP), Molecular Analysis for Therapy Choice (NCI-MATCH), and Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT).
To reach full potential of precision medicine, collaboration among multiple players is required.
Market Taxonomy
This report segments the global precision medicine market on the basis of technology and application. On the basis of technology, the global precision medicine market is segmented into bioinformatics, gene sequencing, drug discovery, precision molecular diagnostics, and big data analytics. Applications of precision medicine include oncology, CNS, hematology, respiratory, and immunology, among others.
Key features of the study:
• This report provides an in-depth analysis of precision medicine in medical sector and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2016 - 2024), considering 2015 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, product pipeline, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global precision medicine market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
• Key companies covered as a part of this study include Novartis AG, Intomics, Ferrer Incode, Nanostring Technologies, Inc., Pfizer, Inc., Teva Pharmaceuticals, Merck & Co., Inc., Qiagen N.V., and Quest Diagnostics
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion and marketing tactics
• The global precision medicine market report caters to various stakeholders in this industry including investors, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the precision medicine market
Detailed Segmentation:
• Global Precision Medicine Market, By Technology:
o Bioinformatics
o Gene Sequencing
o Drug Discovery
o Precision Molecular Diagnostics
o Big Data Analytics
• Global Precision Medicine Market, By Application:
o Oncology
 Breast cancers
 Lung Cancer
 Others
o CNS
o Hematology
o Respiratory
o Immunology
o Others
• Global Precision Medicine Market, By Geography:
o North America
 U.S.
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Canada
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
o Europe
 U.K.
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Germany
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Italy
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 France
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Russia
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Rest of Europe
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
o Asia Pacific
 China
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 India
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Japan
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 ASEAN
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Australia
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 South Korea
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Rest of Asia Pacific
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
o Latin America
 Brazil
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Mexico
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Rest of Latin America
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
o Middle East
 GCC
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Israel
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
o Africa
 North Africa
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Central Africa
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 South Africa
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
• Company Profiles
o Intomics.*
 Company Overview
 Product Portfolio
 Financial Performance
 Key Strategies
 Recent Developments
 Future Plans
o Ferrer Incode
o Nanostring Technologies, Inc.
o Tepnel Pharma Services
o Pfizer, Inc.
o Novartis AG
o Teva Pharmaceuticals
o Merck & Co., Inc.
o Qiagen N.V.
o Quest Diagnostics
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet By Technology
? Market Snippet By Application
? Market Snippet By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o PEST Analysis
o Market Trends
o Value Chain
4. Global Precision Medicine Market, By Technology, 2017 and 2025 (USD Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, 2017 and 2025
? Segment Trends
o Bioinformatics
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
o Gene Sequencing
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
o Drug Discovery
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
o Precision Molecular Diagnostics
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
o Big Data Analytics
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
5. Global Precision Medicine Market, By Application, 2017 and 2025 (USD Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, 2017 and 2025
? Segment Trends
o Oncology
? Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, 2017 and 2025
? Breast Cancer
? Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, 2017 and 2025
? Lung Cancer
? Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, 2017 and 2025
? Others
? Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, 2017 and 2025
o CNS
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
o Hematology
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
o Respiratory
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
o Immunology
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
o Others
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
6. Global Precision Medicine Market, By Regions, 2017 and 2025 (USD Million)
o Introduction
? Market Share Analysis, By Region, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, For Regions, 2017 and 2025
o North America
? Market Share Analysis, By Country, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, By Country, 2017 and 2025
? U.S.
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Canada
? Market Size and Forecast, 2017 and 2025 (USD Million)
o Europe
? Market Share Analysis, By Country, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, By Country, 2017 and 2025
? U.K.
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Germany
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Italy
? Market Size and Forecast, 2017 and 2025 (USD Million)
? France
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Russia
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Others
? Market Size and Forecast, 2017 and 2025 (USD Million)
o Asia Pacific
? Market Share Analysis, By Country, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, By Country, 2017 and 2025
? China
? Market Size and Forecast, 2017 and 2025 (USD Million)
? India
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Japan
? Market Size and Forecast, 2017 and 2025 (USD Million)
? ASEAN
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Australia
? Market Size and Forecast, 2017 and 2025 (USD Million)
? South Korea
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Others
? Market Size and Forecast, 2017 and 2025 (USD Million)
o Latin America
? Market Share Analysis, By Country, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, By Country, 2017 and 2025
? Brazil
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Mexico
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Others
? Market Size and Forecast, 2017 and 2025 (USD Million)
o Africa
? Market Share Analysis, By Country, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, By Country, 2017 and 2025
? Northern Africa
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Central Africa
? Market Size and Forecast, 2017 and 2025 (USD Million)
? South Africa
? Market Size and Forecast, 2017 and 2025 (USD Million)
o Middle East
? Market Share Analysis, By Country, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, By Country, 2017 and 2025
? GCC Countries
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Israel
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Rest of Middle East
? Market Size and Forecast, 2017 and 2025 (USD Million)
7. Competitive Landscape
o Heat Map Analysis
o Company Profiles
? Intomics
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Ferrer Incode
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Nanostring Technologies, Inc.
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Tepnel Pharma Services
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Pfizer, Inc.
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Novartis AG
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Teva Pharmaceuticals
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Merck & Co., Inc.
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Qiagen N.V.
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Quest Diagnostics
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
8. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 23 market data tables and 29 figures on "Precision Medicine Market - Global forecast to 2025".

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.